Quality of Life (QoL) has become a widely used measure in health outcome studies during the past ten years ([@CIT0001]). QoL has been defined as ''the perception that an individual has of his or her place in life, within the context of the culture and system values in which he or she lives, and in relation to the objectives, expectations, standards and concerns of this individual'' ([@CIT0002]). The World Health Organization has also defined Health Related Quality of Life (HRQoL) as ''an integrative measure of physical and emotional well-being, level of independence, social relationships and their relationship to salient features of their environment''. The conceptualization of the term QoL is both objective and subjective and so its measurement requires reference to varied and complex areas. Also, QoL measurement can be very personal as experiences, beliefs, expectations and perceptions of each individual may be unique ([@CIT0003]).

Health-related QoL, irrespective of disease specificity or generality, combines physical, cognitive, emotional, and social functioning experienced and reported by the patient. Further, it can be considered as the appreciation of the pervasive and adverse effects of illness on the patient as perceived by the patient. In other words, it is the "*illness experience* as opposed to the *disease*" ([@CIT0003]). Generic measures of health-related QoL incorporate a broad spectrum of function, health perceptions and symptoms which can be used in different patient populations including those without a disease. This enables direct comparison of QoL across different disease states and conditions. The inherent limitation of generic measures is that they may overlook important aspects or changes that are of particular value for a specific medical condition ([@CIT0004]). Disease-specific measures quantify more clinically relevant domains for a specific disease state than a generic measure. They are often more responsive to changes in health-related QoL and are more sensitive in discriminating the range of impairment in health-related QoL, because their focus is on the most relevant aspects for the problem or condition assessed. Given the breadth and complexity of QoL, it is important to include and assess multiple domains of QoL from a variety of perspectives usually incorporating both generic and specific disease measures. Therefore, the proposed study utilizes cardiac specific QoL as the primary outcome, and generic health-related QoL as the secondary outcome ([@CIT0005], [@CIT0006]).

A chronic condition can be defined as a medical condition that is slow in its progress and long in its continuance. Chronic conditions also increase the costs of health care and long-term care ([@CIT0007]). Measures of the quality of life in chronically ill patients provide an important source of medical information in addition to laboratory or diagnostic tests ([@CIT0008]) and are becoming increasingly relevant in controlled clinical trials ([@CIT0009]). One goal of measuring quality of life is to have objective evaluations of how and how much the disease influences patients' life and how they cope with it. These evaluations may be useful as a baseline and outcome measures and should provide a framework to determine the impact of any change on patients' quality of life ([@CIT0010]). The Iraq- Iran War, also known as the Imposed War by Iranians, was an armed conflict between the armed forces of Iraq and Iran, lasting from September 1980 to August 1988, making it the longest conventional war of the twentieth century ([@CIT0011]). The Iraq- Iran War very costly in lives and material was one of the deadliest wars since World War II ([@CIT0012]). Both countries were devastated by the effect of the war. It cost Iran an estimated one million casualties, killed or wounded, and Iranians still continue to suffer and die as a consequence of Iraq\'s use of chemical weapons. In 2003, nearly 400,000 war veterans were officially registered in the Iranian War Veterans' Foundation. Few studies have addressed the issue of mental health of Iranian war veterans and the few studies which have been conducted in the past three decades have concentrated on physical rather than psychological aspects of this war ([@CIT0013]). Hence, the aim of the present research was to evaluate the relationship between health related quality of life and chronic illness in Iranian psychiatric war veterans.

Materials and Methods {#S0001}
=====================

A cross-sectional design was used to evaluate health related quality of life in psychiatric Iranian war veterans. Nine hundred seventy one psychiatric out patients were thus interviewed and completed questionnaires in individual sessions. Participants came from all parts of the country. The participants were selected by Systematic randomized sampling. For sampling we select one second of patient that refers to War Related Diagnosis Committee in Bonyad Organization (WRDCBO), in 2009 in Tehran, Iran. HRQoL was assessed by means of the 36-item Short-Form Health Status Questionnaire (SF-36), which has been validated for the Iranian population. This questionnaire had been translated to Persian and validated for Iranian population. The internal consistency (to test reliability) showed that all eight SF-36 scales met the minimum reliability standard, the Cronbach\'s alpha coefficients ranging from 0.77 to 0.90 with the exception of the vitality scale (alpha = 0.65) ([@CIT0014]). The SF-36 Health Status Questionnaire is a 36-item multipurpose health survey.

The survey measures eight health concepts. These eight subscales are Physical Functioning (PF), Role-Physical (RP), Bodily Pain BP), General Health (GH), Vitality (VT), Social Functioning (SF), Role-Emotional (RE), and Mental Health (MH). On the basis of these scales, component summary scores were calculated to provide a global measure of physical and mental functioning. The Physical Component Summary (PCS) and the Mental Component Summary (MCS) were derived from the eight multi-item scales. The scales and summary components ranged from 0 to 100, where higher values denote better functioning and fewer limitations ([@CIT0015]).

The SF-36 survey is one of the most widely used surveys to measure health outcomes ([@CIT0013]). The measure can be used across age, disease, or treatment groups. The SF-36 has been beneficial in comparing specific and general populations, comparing the relative burden of disease, screening patients, and differentiating the health benefits produced by a wide range of different treatments ([@CIT0015]).

Participants: 971 male veterans of the Iraq- Iran war who were registered with Iran\'s Martyrs and Veterans' Organization in 2009 participated in the study. The socio-demographic characteristics of participants are demonstrated in [Table 1](#T0001){ref-type="table"}. As shown in the table, 15.2% of veterans are under 40 years of age, 59% between 41 to 50, 12% in the range of 51 to 60, and 4.5% are over 60 years of age.

###### 

Demographic characteristics of veterans

                          Frequency   Percent
  ----------------------- ----------- ---------
  **Age group**                       
     Under 40 years       148         15.2
     41-50 years          573         59
     51-60 years          117         12
     Over 61 years        44          4.5
     Missing              89          9.2
  **Marital Status**                  
     Married              916         94.3
     Single               23          2.4
     Divorced             9           0.9
     Widowed              1           0.1
     No answer            22          2.3
  **Educational Level**               
     Illiterate           61          6.3
     Primary school       565         58.2
     Secondary school     206         21.2
     High school          97          10
     University           10          1
     No answer            32          3.2
  O**ccupation**                      
     Employed             138         14.2
     Unemployed           171         17.6
     Retired              629         64.8
     No answer            32          3.1

Permission to examine medical records was obtained from the patients individually after explaining the purpose of the study. After examining their medical records, veterans were classified into the following groups based on the principle chronic condition for which they were being treated: 1) Respiratory disorders (asthma, chronic bronchitis, emphysema or chronic obstructive pulmonary disease); 2) Musculoskeletal disorders (arthritis, fibromyalgia or back problems); 3) Cardiovascular disorders (high blood pressure or heart disease); 4) Diabetes; 5) Urinary or bowel problems (urinary incontinence, Crohn\'s disease or colitis); and 6) those who were suffering the effects of a stroke. Some chronic conditions, such as food or other allergies, cataracts, glaucoma, and thyroid conditions were not included because their impact on quality of life, as measured by the Health Utilities Index, has previously shown to be indiscernible or mild ([@CIT0016]). Migraine headaches and epilepsy were not considered as their sporadic nature did not lend itself well to a cross-sectional analysis. We first compared veterans who had one or more of the selected chronic conditions with those who reported having no chronic condition, and we subsequently repeated these analyses for each of the above chronic condition groups ([@CIT0017]).

The soft ware of SPSS-18 was used for performing the data analysis. Descriptive statistics and Independent t-test were used to analyze data. The p-values (P ≤ 0.05) were set as the statistically significant level. For Comparison in scores of quality of life between veterans with and without chronic conditions we divide all of participation in 2 groups by DSM-IV classification.

Results {#S0002}
=======

Psychiatric assessment of veterans is demonstrated in [Table 2](#T0002){ref-type="table"} as the number of veterans in each axis of DSM-IV classification. Comparison in scores of quality of life between veterans with and without chronic conditions by use of independent t-test can be seen in [Table 3](#T0003){ref-type="table"}.

###### 

Cannabinoids and their Properties ([@CIT0011])

  Psychoactive components                    
  ------------------------------------------ -------------------------------------------------------------------------------------------------
    ▵^9^-tetrahydrocannabinol                Main psychoactive component; causes psychological and behavioral effects
    (▵^9\_^ THC)                             
    ▵^8\_^tetrahydrocannabinol( ▵^8-^ THC)   Less psychoactive than ▵^9^-THC.
    Cannabinol(CBN)                          Less powerful than ▵^9\_^THC
    11-hydroxy-▵^9\_^ THC (11-OH-THC)        Liable for psychological effects of cannabis
    Anandamide (arachidonylethanolamide)     Imitates activity of ▵^9\_^THC and other cannabinoids that interact with cannabinoid receptors.
  **Non-psychoactive components**            
    Cannabidiol (CBD)                        Lacks psychoactive properties has anticonvulsant action.
    Cannabichromene                          Not psychoactive
    (-)▵^8-^ THC-11-oic acid)                Not psychoactive has analgesic activity.

###### 

Differences of quality of life in different chronic condition with independent t-test

  Dimension of QOL Category   RP     PF       BP        VT        MH       RE       SF        GH       PCS       MCS      
  --------------------------- ------ -------- --------- --------- -------- -------- --------- -------- --------- -------- -------
  **No chronic**              Mean   32.91    58.41     54.43     12.91    15.61    16.18     26.47    27.61     43.48    17.64
  **condition(n = 518)**      (SD)   (40.4)   (28.5)    (27.6)    (8.1)    (8.7)    (19.3)    13.3)    (15.3)    (14.0)   (6.3)
  **One or more**             Mean   27.99    60.85     59.03     10.89    13.68    15.40     28.57    22.75     42.64    17.64
  **chronic condition**       (SD)   (36.7)   (27.8)    (30.0)    (7.6)    (7.7)    (18.8)    (15.3)   (14.1)    (13.1)   (6.3)
  **(n = 453)**               t      -1.55    1.06      1.99      -3.13    -2.85    -0.50     1.82     -4.03     -0.84    -0.67
                              Sig.   0.120    0.289     0.046     0.002    0.005    0.613     0.068    0.001     0.458    0.501
  **Respiratory**             Mean   22.46    52.56     63.30     9.80     12.25    11.30     13.27    20.50     39.70    16.77
  **disorders (n = 177)**     (SD)   (32.8)   (27.1)    (25.6)    (7.3)    (7.70)   (17.1)    (13.1)   (12.7)    (13.0)   (4.9)
                              t      -2.61    -2.36     2.93      -3.54    -3.75    -2.86     4.89     -4.14     -2.85    -1.72
                              Sig.   0.009    0.018     0.003     0.001    0.001    0.004     0.001    0.001     0.006    0.085
  **Musculo- skeletal**       Mean   14.39    50.30     61.36     9.73     14.35    13.02     30.81    24.48     37.63    16.98
  **disorders**               (SD)   (19.7)   (24.7)    (22.6)    (7.0)    (9.2)    (14.5)    (11.5)   (14.9)    (8.8)    (5.0)
  **(n = 38)**                t      -2.36    -1.49     0.87      -1.58    -0.15    -0.72     1.08     -0.20     -2.09    -0.46
                              Sig.   0.018    0.135     0.389     0.114    0.880    0.472     0.279    0.839     0.036    0.600
  **Cardio- vascular**        Mean   28.38    59.71     56.73     10.68    13.76    15.96     29.38    24.25     40.68    17.47
  **disorders**               (SD)   (38.7)   (28.8)    (29.70)   (7.4)    (7.6)    (18.41)   (14.6)   (13.3)    (13.6)   (4.8)
  **(n = 143)**               t      -0.46    -1.96     -0.18     -1.74    -1.12    0.36      1.01     -0.59     -1.52    0.03
                              Sig.   0.644    0.050     0.855     0.081    0.262    0.715     0.311    0.554     0.127    0.974
  **Diabetes**                Mean   33.87    58.27     53.07     9.95     12.58    18.81     27.66    21.60     42.18    17.23
  **(n = 73)**                (SD)   (40.7)   (29.5)    (34.8)    (7.0)    (8.1)    (19.9)    (15.9)   (14.5)    (12.6)   (4.3)
                              t      0.84     0.21      -1.17     -1.98    -1.94    1.49      -0.28    -1.88     -0.18    -0.32
                              Sig.   0.399    0.829     0.239     0.047    0.052    0.135     0.774    0.060     0.857    0.749
  **Urinary or bowel**        Mean   27.73    54.68     65.87     11.22    12.85    16.4.     30.11    19.50     42.56    17.65
  **disorders**               (SD)   (33.3)   (27.1)    (26.5)    (80.0    (8.27)   ()18.0    (15.8)   (12.5)    (11.7)   (5.8)
  **(n = 86)**                t      -0.47    -0.83     2.55      -0.66    -1.70    0.45      1.14     -3.11     0.04     0.26
                              Sig.   0.638    0.407     0.011     0.504    0.089    0.653     0.252    0.002     0.964    0.788
  **Stroke**                  Mean   18.75    21.87     70.31     4.87     8.54     10.41     38.43    15.82     31.69    15.24
  **(n = 10)**                (SD)   (25.8)   (23.74)   (29.07)   (5.45)   (5.4)    (15.2)    (12.8)   (13.61)   (9.2)    (3.0)
                              t      -0.82    -3.60     1.32      -2.52    -1.92    -0.74     2.07     -1.76     -2.25    -1.01
                              Sig.   0.411    0.001     0.186     0.012    0.054    0.456     0.039    0.078     0.024    0.313

As demonstrated, veterans with one or more chronic conditions have reported more bodily pain and less vitality, mental and general health than those without chronic conditions. Veterans with respiratory disorders have reported lower scores of quality of life in all dimensions compared to those without respiratory disease.

Compared to their healthy counterparts, psychiatric veterans with musculoskeletal disorders reported lower scores on physical role and physical component summary. Further, diabetics had lower scores on vitality. Also, veterans suffering from urinary and bowel disorders showed higher level of bodily pain and lower level of general health, and those suffering from effects of stroke reported lower physical functioning, social functioning, and vitality as well as physical component summary. Findings showed no significant difference between psychiatric patients with or without cardiovascular disease.

Discussion {#S0003}
==========

Measures of quality of life in chronically ill patients provide an important source of medical information for promoting life satisfaction and health status ([@CIT0016]). One goal of measuring quality of life is to obtain an objective evaluation of how and how much the disease influences patients' life and how patients cope with it ([@CIT0018]).

The present findings show that bodily pain, vitality, mental health, and general health are lower in psychiatric veterans with one or more chronic condition than those without chronic conditions. This finding suggests that chronic pain may be considered as a threat to psychological well being of psychiatric patients. Patients with respiratory disorders experience a progressive deterioration and disability which leads to a worsening in their health-related quality of life. Shafazand (2004) reported significant impairment in all domains of quality of life in respiratory disorders, including energy, emotional reaction, pain, physical mobility, sleep, and social isolation compared to patients without respiratory disorders ([@CIT0019]).

Similarly, Taichman (2005) studied 155 patients with respiratory disorders, employing another widely used generic measure, the SF-36, in addition to a popular respiratory-specific measure, the St. George\'s Respiratory Questionnaire (SGRQ) ([@CIT0020]). Both the physical and mental component summary scores of the SF-36 (PCS and MCS) were significantly depressed, demonstrating scores comparable with those of other debilitating and life-threatening conditions such as spinal cord injury and metastatic cancer. All domains were affected, with the greatest impairment observed in the general health, physical functioning, and role-physical and role-emotional domains. The SGRQ, and each of its subscales, also demonstrated evidence of substantial impairment. In a subset of patients, the SF-36 PCS correlated reasonably well with other physical assessments, such as 6-minute walk distance (6MWD) (r = 0.62) and the body mass index (BMI) (r = 0.46), Providing evidence of both convergent and divergent validity.

Results of the present study show that psychiatric veterans with musculoskeletal disorders have lower physical role and physical component summary in quality of life than matched ones without musculoskeletal disorders. A number of studies have examined and reported relationships between Musculoskeletal symptoms and diminished physical health related quality of life ([@CIT0021]--[@CIT0026], [@CIT0016]). Studies have demonstrated that physical activity can improve quality of life in adults with chronic conditions. These associations have typically been examined with respect to a particular chronic condition, such as arthritis ([@CIT0027], [@CIT0028]). Findings of this present study do not show any differences between psychiatric veterans with or without cardiovascular disease.

Juenger et al ([@CIT0029]) compared the quality of life of patients suffering from cardiovascular disease with a previously characterized general population as well as those with other chronic diseases. The authors concluded that the total cardiovascular disease sample was characterized by significantly reduced scores in all aspects of quality of life compared with a healthy reference group. Patients with cardiovascular disease showed the same pattern of reduced quality of life as patients on chronic hemodialysis. Thus, it could be argued that all chronic disease conditions have a similar impact on quality of life.

Our findings on cardiovascular disease in psychiatric veterans do not support this conclusion. Our population has an extended network across the country that is supported by veteran affair organization which provides financial support for them. We can consider this factor as one determinant factor that prevents severe fallacy in quality of life in psychiatric veterans with cardio vascular disease. Numerous studies of cardiac patients (coronary heart disease patients) have reported that lack of social support and social isolation are associated with increased risk of mortality, but the study undertaken by Murberg et al (2001) was the first in detecting the effect of social isolation (a patient\'s perception that he or she is no longer able to maintain the same degree of social contacts and activities with family, other relatives and friends as previously) on mortality among cardiovascular patients ([@CIT0009]). Another finding concerns the relationship between the lack of intimate network support and mortality: for cardiovascular patients, most of them elderly, lack of social support from a spouse seems to be more of a critical factor of fatal outcome than the lack of social support from a primary and secondary network. The authors pointed to two possible explanations: 1) poor network support might be associated with poor compliance to physical and medical regimens and that poor compliance may lead, in turn, to a dismal outcome; 2) it could be also that the association between social isolation and mortality is a reflection of some underlying factors such as subjective health or hopelessness, which have been reported in several studies to be strong predictors of mortality independently of depression ([@CIT0018]).

Our findings revealed that diabetic psychiatric veterans have lower vitality than patients without diabetes. Several studies show that diabetes has detrimental effects on a range of health outcomes including health-related quality of life ([@CIT0030], [@CIT0031], [@CIT0032]). For example, in the Medical Outcomes Study, diabetes was found to impair all dimensions of health except mental health and pain. In one multinational study, it was found to have a notable impact on general health, measured using the Medical Outcomes Short-Form 36 (SF-36) ([@CIT0033]). Our study showed that in a psychiatric patient, diabetes influences only vitality as a dimension of quality of life.

Another factor that should be considered is that subjects with diabetes and multiple co-existing chronic medical conditions have poorer health-related quality of life than those without these conditions ([@CIT0034], [@CIT0035]). For example, subjects with diabetes and co-existing cardiovascular diseases reported significantly lower scores on RAND-36 social functioning, vitality and health-change scales ([@CIT0034]). In another study, subjects with diabetes and co-existing coronary artery disease, peripheral sensory neuropathy and peripheral vascular diseases reported significantly lower scores on several SF-36 scales ([@CIT0035]).

In this present study, we demonstrated that psychiatric veterans with urinary and bowel disorders have higher level of bodily pain and lower level of general health. Previous researchers have pointed out that the research on the impact of urinary and bowel disorders have not adequately addressed the role that co morbidity may play in the relationship between urinary incontinence and quality of life ([@CIT0036]). However, some researchers have found that the effects of incontinence on quality of life are mild or confined to a relatively small portion of the population ([@CIT0037], [@CIT0038], [@CIT0039]). Our findings are consistent with several other studies that found that urinary and bowel disorders have greater negative effects on quality of life ([@CIT0037], [@CIT0040], [@CIT0041], [@CIT0042]).

Finally, we found that psychiatric veterans with stroke have lower physical, social functioning, vitality, and physical component summary than matched ones without stroke. Stroke is a major cause of disability, and when severe, it has a substantial adverse impact on the stroke survivors' health-related quality of life. Factors that have been shown to be consistently associated with lower HRQOL include depression, lower functional status, and greater severity of paralysis. The much lower physical functioning score suggests that many of these patients still encountered limitations or difficulties with their physical activities ([@CIT0043]). Our findings confirm that psychiatric veterans with stroke have lower physical activity.

In particular, studies investigating determinants of HRQL following stroke suggest that social functioning may be more important than physical functioning in determining. It is not surprising that social relationships emerged as a major determinant of QoL for stroke patients. An important impact of a stroke is a radical shift in social roles. The reactions and behaviors of socially significant others impacts the QoL of the stroke survivor. In fact, surviving a stroke is necessarily a social effort. A majority of stroke survivors must depend on others for everyday activities ([@CIT0044]). Therefore, social relationships are critical for the patients' survival after suffering a stroke, and are of prime importance in QoL of these patients.
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